McKesson, CD&R buy infusion therapy provider Option Care Health in $5.8 billion deal

OPCH•2026-10-06

McKesson and Clayton Dubilier & Rice agreed to buy Option Care Health in a deal worth about $5.8 billion.

1. Deal agreement

Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to buy infusion therapy provider Option Care Health in a deal worth about $5.8 billion.

McKesson, CD&R buy infusion therapy provider Option Care Health in $5.8 billion deal

1. Deal agreement

Related News

TowneBank agrees to buy blueharbor bank for $154 million

ArriVent falls after lung cancer drug misses late-stage trial goal

Lincoln National Corp: UBS raises target price to $46 from $44

Diversified Healthcare Trust announces 15-year net lease with The Ensign Group for Colorado skilled nursing portfolio

Copper drifts higher on rally in tech stocks and weaker dollar